US FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test – StreetInsider.com / Common Stock Warrants, US Warrant News / By https://commonstockwarrants.com US FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test StreetInsider.com